F. Maindrault-Gœbel, G. LLedo, B. Chibaudel, L. Mineur, T. André, M. Bennamoun, M. Mabro,
Part III – Individualizing Therapy in NSCLC Tuesday, June 28, 2011 7:30 PM – 8:30 PM ET RTP TV: An 8-Part Live CME Webcast Series.
SATURN: A double-blind, randomized, phase III study of maintenance erlotinib versus placebo following non-progression with 1st-line platinum-based chemotherapy.